Insights

Moberg Pharma AB (publ)

Nasdaq Stockholm · LEI 549300XFXK7DVGDRP410· Fiscal year 2025

Staff cost per employee
Not disclosed
Employees
Not disclosed

Quick read

  • Operating loss of $2.7M in 2025.

Last 3 years

Revenue
Not disclosed$1.3M2025
Operating income
-$31.9M2024-$2.7M2025

See the share price on Google Finance ↗

Investor metrics

2025
Operating margin
-201.8%
Net margin
-201.2%
ROE
-4.1%
Debt-to-equity
2.6%
Equity ratio
97.5%

USD at SEK 10.18 per $1 (2026-11-20, ExchangeRate-API)

Staff costs from the annual report (wages, social charges, pensions) divided by the average number of employees. Usually higher than take-home pay.

audited consolidated financial statements · View the annual report (filings.xbrl.org)

Not investment advice. Figures come from public filings and may contain errors.